Some Drug Prices Could Drop 40% Under Canada’s Cost Lowering Proposals
The prices of patented medicines overall are expected to go down in Canada under new proposed regulatory amendments.
You may also be interested in...
Long awaited changes to Canada’s Patented Medicines Regulations have been announced, but companies will have to wait for new guidelines from the pricing watchdog to better understand how they will be implemented.
Generic drug manufacturers in Canada have agreed to price cuts of up to 40% to stave off tendering.
Companies operating in Canada could face pharmacoeconomic evaluations to decide if drugs are over-priced as well as a requirement to disclose information that could impair the confidentiality of pricing agreements.